Please use this identifier to cite or link to this item:
|Title:||Real-world treatment in patients with HER2+ metastatic breast cancer : Treatment decisions in HER2+ mBC.|
Antineoplastic Combined Chemotherapy Protocols
Practice Guidelines as Topic
Practice Patterns, Physicians'
|Citation:||Breast Cancer Res. Treat..2018 Feb;(168)1:197-205|
|Abstract:||The landscape of HER2+ metastatic breast cancer (mBC) treatment is changing due to the availability of new anti-HER2 drugs. The purpose of this study was to assess the current treatment patterns and sequences used in HER2+ mBC in the real-world setting. Secondary objectives were to describe the factors that influence the decision to prescribe a first and second-line antitumour treatment.|
|Appears in Collections:||Fundaciones e Institutos de Investigación > IIS H. U. La Princesa > Artículos|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.